Suvretta Capital Management’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.2M | Buy |
3,360,000
+1,796,202
| +115% | +$8.1M | 0.46% | 48 |
|
|
2025
Q1 | $7.26M | Hold |
1,563,798
| – | – | 0.27% | 56 |
|
|
2024
Q4 | $10.9M | Sell |
1,563,798
-1,095,202
| -41% | -$7.6M | 0.37% | 52 |
|
|
2024
Q3 | $14.1M | Hold |
2,659,000
| – | – | 0.45% | 48 |
|
|
2024
Q2 | $9.94M | Buy |
+2,659,000
| New | +$9.94M | 0.37% | 50 |
|
|
2021
Q3 | – | Sell |
-150,000
| Closed | -$3.41M | – | 113 |
|
|
2021
Q2 | $3.41M | Buy |
+150,000
| New | +$3.41M | 0.05% | 97 |
|